$IMG
Stock $img

$img Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000149315222036487 Filed on December 23, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2022
Revenue	$1.136M	$600.8K	$3.109M
YoY Change	11.49%	23.99%	61.38%
Cost Of Revenue	$1.061M	$643.9K	$3.220M
YoY Change	5.67%	-1.53%	60.44%
Gross Profit	$75.53K	-$43.11K	-$110.4K
YoY Change	391.42%	-74.54%	37.86%
Gross Profit Margin	6.65%	-7.18%	-3.55%
Selling, General & Admin	$91.12K		$10.62M
YoY Change			465.59%
% of Gross Profit	120.64%
Research & Development			$633.00
YoY Change			-65.6%
% of Gross Profit
Depreciation & Amortization	$73.81K	$84.29K	$379.5K
YoY Change	101.05%	-6.07%	10.1%
% of Gross Profit	97.71%
Operating Expenses	$2.277M	$2.063M	$11.29M
YoY Change	-19.0%	-38.19%	-36.27%
Operating Profit	-$2.202M	-$2.106M	-$11.40M
YoY Change	-21.25%	-39.95%	-35.94%
Interest Expense	$3.520K	-$900.00	$6.324K
YoY Change	-194.62%	-86.99%	-128.38%
% of Operating Profit
Other Income/Expense, Net	$14.95K	-$354.1K	$574.7K
YoY Change	-420.13%	-3609.22%	424.27%
Pretax Income	-$2.183M	-$3.136M	-$11.80M
YoY Change	-22.14%	-10.49%	-36.41%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$2.183M	-$3.136M	-$11.80M
YoY Change	-22.15%	-10.49%	-36.41%
Net Earnings / Revenue	-192.12%	-521.94%	-379.45%
Basic Earnings Per Share	-$3.23		-$0.61
Diluted Earnings Per Share	-$3.23	-$4.980M	-$21.32M
COMMON SHARES
Basic Shares Outstanding	23.67M shares	23.67M shares	19.37M shares
Diluted Shares Outstanding	676.4K shares		553.3K shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.492M	$8.315M	$8.315M
YoY Change	-40.81%	-23.12%	-23.12%
Cash & Equivalents	$6.492M	$8.315M
Short-Term Investments
Other Short-Term Assets	$376.3K	$547.8K	$547.8K
YoY Change	-44.09%	17.98%	17.98%
Inventory	$1.090M	$948.0K	$948.0K
Prepaid Expenses
Receivables	$653.9K	$345.3K	$345.3K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.612M	$10.16M	$10.16M
YoY Change	-32.82%	-18.27%	-18.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$475.3K	$525.1K	$1.168M
YoY Change	-59.81%	-22.1%	8.26%
Goodwill
YoY Change
Intangibles	$132.5K	$140.0K
YoY Change
Long-Term Investments	$167.8K	$169.6K	$169.6K
YoY Change	-3.71%	-3.31%	-3.31%
Other Assets	$91.98K	$77.96K	$77.96K
YoY Change	15.57%	-2.33%	-2.33%
Total Long-Term Assets	$1.437M	$1.555M	$1.555M
YoY Change	0.05%	18.2%	16.6%
TOTAL ASSETS
Total Short-Term Assets	$8.612M	$10.16M	$10.16M
Total Long-Term Assets	$1.437M	$1.555M	$1.555M
Total Assets	$10.05M	$11.71M	$11.71M
YoY Change	-29.51%	-14.78%	-14.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$462.7K	$113.7K	$113.7K
YoY Change	-32.12%	-66.83%	-66.83%
Accrued Expenses	$624.3K	$706.5K	$1.095M
YoY Change	86.57%	157.84%	157.64%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$36.73K	$32.47K	$32.47K
YoY Change	-39.13%	-54.56%	-54.56%
Total Short-Term Liabilities	$1.830M	$1.600M	$1.600M
YoY Change	22.1%	38.69%	38.69%
LONG-TERM LIABILITIES
Long-Term Debt	$21.24K	$34.37K	$34.37K
YoY Change	-61.07%	-45.67%	-45.67%
Other Long-Term Liabilities	$77.34K	$66.48K	$334.3K
YoY Change	-81.43%	1.04%	6.64%
Total Long-Term Liabilities	$283.9K	$368.6K	$368.6K
YoY Change	-39.73%	-2.15%	-2.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.830M	$1.600M	$1.600M
Total Long-Term Liabilities	$283.9K	$368.6K	$368.6K
Total Liabilities	$2.114M	$1.969M	$1.969M
YoY Change	7.31%	28.64%	28.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$66.81M	-$64.62M
YoY Change		22.33%
Common Stock	$74.54M	$74.28M
YoY Change		14.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.935M	$9.743M	$9.743M
YoY Change
Total Liabilities & Shareholders Equity	$10.05M	$11.71M	$11.71M
YoY Change	-29.51%	-14.78%	-14.78%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2022
OPERATING ACTIVITIES
Net Income	-$2.183M	-$3.136M	-$11.80M
YoY Change	-22.15%	-10.49%	-36.41%
Depreciation, Depletion And Amortization	$73.81K	$84.29K	$379.5K
YoY Change	101.05%	-6.07%	10.1%
Cash From Operating Activities	-$1.913M	-$1.785M	-$7.462M
YoY Change	21.12%	-6.19%	4.99%
INVESTING ACTIVITIES
Capital Expenditures	$16.51K	$22.75K	$191.8K
YoY Change	-648.64%	-12.8%	-266.23%
Acquisitions			$413.1K
YoY Change
Other Investing Activities		$0.00	-$413.1K
YoY Change
Cash From Investing Activities	-$16.51K	$22.76K	-$604.8K
YoY Change	448.64%	-12.76%	424.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$95.26K
YoY Change			-99.31%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$8.857K	2.648M	$5.680M
YoY Change	-100.52%	-12215.0%	-58.33%
NET CHANGE
Cash From Operating Activities	-$1.913M	-1.785M	-$7.462M
Cash From Investing Activities	-$16.51K	22.76K	-$604.8K
Cash From Financing Activities	-$8.857K	2.648M	$5.680M
Net Change In Cash	-$1.823M	886.3K	-$2.501M
YoY Change	-1639.11%	-146.69%	-139.02%
FREE CASH FLOW
Cash From Operating Activities	-$1.913M	-$1.785M	-$7.462M
Capital Expenditures	$16.51K	$22.75K	$191.8K
Free Cash Flow	-$1.930M	-$1.808M	-$7.654M
YoY Change	22.4%	-6.28%	9.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001527613
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2021	us-gaap	Restricted Stock Expense RestrictedStockExpense		usd
CY2022	NUZE	Common Stock Issued For Compensation CommonStockIssuedForCompensation		usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment		usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2022	NUZE	Proceeds From Issuance Of Equity Securities Net Of Issuance Costs ProceedsFromIssuanceOfEquitySecuritiesNetOfIssuanceCosts		usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021	NUZE	Proceeds From Issuance Of Common Stock Exercise Of Warrants Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockExerciseOfWarrantsNetOfIssuanceCosts		usd
CY2021	NUZE	Proceeds From Issuance Of Equity Securities Exempt Offering Net Of Issuance Costs ProceedsFromIssuanceOfEquitySecuritiesExemptOfferingNetOfIssuanceCosts		usd
CY2021	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity		usd
CY2021	NUZE	Proceeds From Cash Paid For Offering Costs ProceedsFromCashPaidForOfferingCosts		usd
CY2021	us-gaap	Stock Issued1 StockIssued1		usd
CY2021	NUZE	Stock Issuance Cost Accrued StockIssuanceCostAccrued		usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2021Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2022Q3	us-gaap	Goodwill Goodwill		usd
CY2021Q3	us-gaap	Goodwill Goodwill		usd
CY2021Q3	us-gaap	Goodwill Goodwill		usd
CY2022Q3	us-gaap	Goodwill Goodwill		usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2021	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Exercised Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExercisedNumberOfShares		shares
CY2021	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Exercised Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExercisedWeightedAverageGrantDateFairValue
CY2022	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Exercised Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExercisedNumberOfShares		shares
CY2022	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Exercised Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExercisedWeightedAverageGrantDateFairValue
CY2021Q3	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
CY2022	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022Q3	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding		usd
CY2022	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Exercisable Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsExercisableAggregateIntrinsicValueNonvested		usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2021	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
CY2021	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2021Q3	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding		usd
CY2021	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Exercisable Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsExercisableAggregateIntrinsicValueNonvested		usd
CY2021Q3	NUZE	Deferred Tax Assets Fixed Assets And Intangible Assets DeferredTaxAssetsFixedAssetsAndIntangibleAssets		usd
CY2022Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39338
CY2022	dei	Entity Registrant Name EntityRegistrantName	NUZEE, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3849791
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1350 East Arapaho Road
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite #230
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Richardson
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75081
CY2022	dei	City Area Code CityAreaCode	(760)
CY2022	dei	Local Phone Number LocalPhoneNumber	295-2408
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.00001 par value
CY2022	dei	Trading Symbol TradingSymbol	NUZE
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	dei	Entity Public Float EntityPublicFloat	28852352	usd
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23668017	shares
CY2022	dei	Auditor Firm AuditorFirmId	206
CY2022	dei	Auditor Name AuditorName	MaloneBailey, LLP
CY2022	dei	Auditor Location AuditorLocation	Houston, Texas
CY2022Q3	us-gaap	Cash Cash	8315053	usd
CY2021Q3	us-gaap	Cash Cash	10815954	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	345258	usd
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	555238	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	947995	usd
CY2021Q3	us-gaap	Inventory Net InventoryNet	573464	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	547773	usd
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	482288	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	10156079	usd
CY2021Q3	us-gaap	Assets Current AssetsCurrent	12426944	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	525075	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	674024	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	642624	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	386587	usd
CY2022Q3	us-gaap	Investments Investments	169634	usd
CY2021Q3	us-gaap	Investments Investments	175425	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	140000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	77962	usd
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	79822	usd
CY2022Q3	us-gaap	Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment	1030220	usd
CY2021Q3	us-gaap	Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment	641834	usd
CY2022Q3	us-gaap	Assets Assets	11711374	usd
CY2021Q3	us-gaap	Assets Assets	13742802	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	113708	usd
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	342790	usd
CY2022Q3	us-gaap	Loans Payable Current LoansPayableCurrent	7947	usd
CY2021Q3	us-gaap	Loans Payable Current LoansPayableCurrent	43618	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	388325	usd
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	150931	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	24518	usd
CY2021Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	27833	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	706492	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	274009	usd
CY2022Q3	us-gaap	Deferred Income Current DeferredIncomeCurrent	319707	usd
CY2021Q3	us-gaap	Deferred Income Current DeferredIncomeCurrent	175822	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	39241	usd
CY2021Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	138631	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1599938	usd
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1153634	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	267786	usd
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	247656	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	29622	usd
CY2021Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	50567	usd
CY2022Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	4745	usd
CY2021Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	12696	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	66484	usd
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	65802	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	368637	usd
CY2021Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	376721	usd
CY2022Q3	us-gaap	Liabilities Liabilities	1968575	usd
CY2021Q3	us-gaap	Liabilities Liabilities	1530355	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23668017	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23668017	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17820390	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17820390	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	236	usd
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	178	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	74281189	usd
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	64839254	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64622520	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-52824808	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	83894	usd
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	197823	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9742799	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	12212447	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11711374	usd
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13742802	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3109162	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1926660	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	3219575	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	2006753	usd
CY2022	us-gaap	Gross Profit GrossProfit	-110413	usd
CY2021	us-gaap	Gross Profit GrossProfit	-80093	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10616971	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17080792	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	675134	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	840391	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	11292105	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	17921183	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-11402518	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-18001276	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	191631	usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	144452	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-5791	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	-7889	usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	574710	usd
CY2021	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	672929	usd
CY2022	us-gaap	Interest Expense InterestExpense	6324	usd
CY2021	us-gaap	Interest Expense InterestExpense	14388	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11797712	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-18552030	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.13
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19366276	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16413162	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11797712	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-18552030	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-113929	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	7662	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-113929	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	7662	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11911641	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18544368	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	12212447	usd
CY2022	NUZE	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	1702596	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	95256	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1649736	usd
CY2022	NUZE	Stock Issued During Period Value Cash Registered Offering Net Of Issuance Costs StockIssuedDuringPeriodValueCashRegisteredOfferingNetOfIssuanceCosts	2520868	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	426844	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2899338	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12600	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	134755	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-113929	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11797712	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9742799	usd
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	6389758	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13701284	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1251402	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	9405191	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9180	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	7662	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	7662	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-18552030	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	12212447	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11797712	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-18552030	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	379474	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	344669	usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense	302334	usd
CY2021	us-gaap	Other Noncash Expense OtherNoncashExpense	278060	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-12618	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	2899338	usd
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	9405191	usd
CY2022	us-gaap	Restricted Stock Expense RestrictedStockExpense	134755	usd
CY2021	NUZE	Common Stock Issued For Compensation CommonStockIssuedForCompensation	1251402	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	34351	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-5791	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	-7889	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	675134	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	840391	usd
CY2022	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	368783	usd
CY2021	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	477605	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-175629	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	359628	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	364867	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	328094	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	65485	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	283655	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1860	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-737	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-229845	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	293012	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	143885	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	141822	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-300847	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-260804	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	162001	usd
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-407817	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	682	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	44095	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7462121	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7107155	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	191765	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	115361	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	413069	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-604834	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-115361	usd
CY2021	NUZE	Proceeds From Issuance Of Equity Securities Net Of Issuance Costs ProceedsFromIssuanceOfEquitySecuritiesNetOfIssuanceCosts	13701284	usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	43622	usd
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	56603	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	95256	usd
CY2022	NUZE	Proceeds From Issuance Of Common Stock Exercise Of Warrants Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockExerciseOfWarrantsNetOfIssuanceCosts	1702596	usd
CY2022	NUZE	Proceeds From Issuance Of Equity Securities Exempt Offering Net Of Issuance Costs ProceedsFromIssuanceOfEquitySecuritiesExemptOfferingNetOfIssuanceCosts	1649736	usd
CY2022	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	2656460	usd
CY2022	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	24260	usd
CY2021	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	21598	usd
CY2022	NUZE	Proceeds From Cash Paid For Offering Costs ProceedsFromCashPaidForOfferingCosts	-368783	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12600	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9180	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5679983	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13632263	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-113929	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7662	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2500901	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6417409	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10815954	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4398545	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8315053	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10815954	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	9811	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2871	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	800	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	800	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	426844	usd
CY2022	NUZE	Stock Issuance Cost Accrued StockIssuanceCostAccrued	135592	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	558371	usd
CY2022	NUZE	Recalssification From Operating Expenses To Other Expenses RecalssificationFromOperatingExpensesToOtherExpenses	477605	usd
CY2021	NUZE	Recalssification From Operating Expenses To Other Expenses RecalssificationFromOperatingExpensesToOtherExpenses	160489	usd
CY2021Q3	NUZE	Recalssification From Capitalized Software Costs To Other Assets RecalssificationFromCapitalizedSoftwareCostsToOtherAssets	18000	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9307921	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9343606	shares
CY2022Q3	us-gaap	Cash Cash	8315053	usd
CY2022Q3	NUZE	Working Capital WorkingCapital	8556141	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	349890	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	250523	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	67310	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_zIzT6jgT3eE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_zY4XXn0v2Koi">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	7662	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1702596	usd
CY2022Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2021Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zRRIEbw39uwi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zIuiG6FnqlLe">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company places its cash with high quality banking institutions. From time to time, the Company may or may not maintain cash balances at certain institutions in excess of the Federal Deposit Insurance Corporation limit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	667723	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	11612	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	656111	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	388325	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	267786	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6862	usd
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y8M12D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	386587	usd
CY2022	NUZE	Addition For Right Of Use Of Assets AdditionForRightOfUseOfAssets	558371	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	302334	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	642624	usd
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	398587	usd
CY2022	NUZE	Addition For Lease Liability AdditionForLeaseLiability	558371	usd
CY2022	NUZE	Operating Lease Lease Liability Amortization Expense OperatingLeaseLeaseLiabilityAmortizationExpense	300847	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	656111	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	388325	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	267786	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	656111	usd
CY2022Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2022Q3	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.1275	pure
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	8853	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	33113	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	27594	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	60707	usd
CY2022Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	6567	usd
CY2022Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	54140	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	24518	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	29622	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	320813	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	162096	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	373968	usd
CY2022	NUZE	Finance Leases Payment FinanceLeasesPayment	7594	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	24260	usd
CY2022	us-gaap	Lease Income LeaseIncome	185139	usd
CY2022Q3	NUZE	Sub Lease Liability Payments Due Next Twelve Months SubLeaseLiabilityPaymentsDueNextTwelveMonths	126971	usd
CY2022Q3	NUZE	Sublease Liability Payments Due Year Two SubleaseLiabilityPaymentsDueYearTwo	97377	usd
CY2022Q3	NUZE	Minimum Lease Payments To Be Received Sublease MinimumLeasePaymentsToBeReceivedSublease	224348	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-113929	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	192316	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	227845	usd
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	482288	usd
CY2021Q3	us-gaap	Public Utilities Property Plant And Equipment Vehicles PublicUtilitiesPropertyPlantAndEquipmentVehicles	76267	usd
CY2022Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	62122	usd
CY2021Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	122698	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1540953	usd
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1319909	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	525075	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	633	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1840	usd
CY2022	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardTerms	P10Y
CY2021	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardTerms	P10Y
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	14000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	563016	shares
CY2022	us-gaap	Other Expenses OtherExpenses	574710	usd
CY2021	us-gaap	Other Expenses OtherExpenses	672929	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	547773	usd
CY2021Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	482288	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	547773	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	947995	usd
CY2021Q3	us-gaap	Inventory Net InventoryNet	573464	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4511691	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.73
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	887632	usd
CY2021Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	552621	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	60363	usd
CY2021Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	20843	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	947995	usd
CY2021Q3	us-gaap	Inventory Net InventoryNet	573464	usd
CY2022	us-gaap	Depreciation Depreciation	333196	usd
CY2021	us-gaap	Depreciation Depreciation	344699	usd
CY2022	NUZE	Property And Equipment Description PropertyAndEquipmentDescription	Expenditures associated with upgrades and enhancements that improve, add functionality, or otherwise extend the life of property and equipment that exceed $1,000 are capitalized
CY2022Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1930898	usd
CY2021Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1794968	usd
CY2022Q3	us-gaap	Public Utilities Property Plant And Equipment Vehicles PublicUtilitiesPropertyPlantAndEquipmentVehicles	73008	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	674024	usd
CY2022	NUZE	Purchase Of Deposit Equipment PurchaseOfDepositEquipment	0	usd
CY2021	NUZE	Purchase Of Deposit Equipment PurchaseOfDepositEquipment	0	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y4M24D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	452206	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	185000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.31
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	14000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.90
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	144000	shares
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	840391	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	531412	usd
CY2021Q3	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	0	usd
CY2022	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	greater than 50% likelihood
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	368673	usd
CY2020Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	762917	shares
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	10.60
CY2022Q3	us-gaap	Other Liabilities OtherLiabilities	8553	usd
CY2021Q3	us-gaap	Other Liabilities OtherLiabilities	99760	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3366681	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.88
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	31111	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	31111	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	31111	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	31111	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	15556	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	140000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	531412	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3109162	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1926660	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	525075	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	674024	usd
CY2022Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	884778	shares
CY2022Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.00
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	531412	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	531412	usd
CY2022Q3	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	140000	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	316328	shares
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	330000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	46278	usd
CY2022Q3	NUZE	Finite Lived Intangible Assets Impairment Charge FiniteLivedIntangibleAssetsImpairmentCharge	143722	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	140000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	46278	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1649736	usd
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	2.00
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	19.42
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	563016	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.12
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3975675	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.28
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1207	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2226557	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.59
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y6M
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	469657	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1620667	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.74
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M18D
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	19112118	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3366681	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.88
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.53
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	469657	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	9.29
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4511691	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.73
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y4M24D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	452206	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1640892	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.64
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y3M18D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	7.66
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	942471	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	8.16
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	2870799	shares
CY2020Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	5.02
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	185000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.84
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	563016	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	3.09
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	743665	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	6.11
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1749118	shares
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	4.41
CY2020Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	40250	shares
CY2020Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	9.00
CY2020Q2	us-gaap	Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable	2020-12-23
CY2020Q2	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2025-06-18
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	4831915	shares
CY2021Q3	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1	4.98
CY2021	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm	P4Y6M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	884778	shares
CY2022	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Granted In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantedInPeriodWeightedAverageExercisePrice	2.00
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	384447	shares
CY2022	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice	4.51
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	5332246	shares
CY2022Q3	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1	4.52
CY2022	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm	P3Y8M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Other ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther	5332246	shares
CY2022	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercisable In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisableInPeriodWeightedAverageExercisePrice	4.52
CY2022	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTermExercisable	P3Y8M12D
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1702596	usd
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	40250	shares
CY2020Q3	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1	9.00
CY2020	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm	P4Y8M12D
CY2020Q3	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding	321598	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	4791665	shares
CY2021	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Granted In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantedInPeriodWeightedAverageExercisePrice	4.95
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	4831915	shares
CY2021Q3	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1	4.98
CY2021	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm	P4Y6M
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Other ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther	4831915	shares
CY2021	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercisable In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisableInPeriodWeightedAverageExercisePrice	4.98
CY2021	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTermExercisable	P4Y6M
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	NUZE	Deferred Income Tax Assets Valuation Allowance Percentage DeferredIncomeTaxAssetsValuationAllowancePercentage	1	pure
CY2022Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	37663761	usd
CY2021Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	27750819	usd
CY2022	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	The earliest tax year which remains open to examination is 2019.
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10263914	usd
CY2021Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7770229	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5775567	usd
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4926021	usd
CY2022Q3	NUZE	Deferred Tax Assets Fixed Assets And Intangible Assets DeferredTaxAssetsFixedAssetsAndIntangibleAssets	168498	usd
CY2022Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	16207979	usd
CY2021Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12696250	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16207979	usd
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12696250	usd
CY2022	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_800_eus-gaap--LossContingencyDisclosures_za4UFImSXgKf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11. <span id="xdx_827_zTXDdZP1qP54">CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, we may be subject to legal proceedings and claims in the ordinary course of business. The results of any future litigation cannot be predicted with certainty, and, regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors. Matters that are probable of unfavorable outcomes to us and which can be reasonably estimated are accrued. Such accruals are based on information known about the matters, our estimates of the outcomes of such matters and our experience in contesting, litigating and settling similar matters.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>

Files In Submission

Name	View Source	Status
0001493152-22-036487-index-headers.html	Edgar Link	pending
0001493152-22-036487-index.html	Edgar Link	pending
0001493152-22-036487.txt	Edgar Link	pending
0001493152-22-036487-xbrl.zip	Edgar Link	pending
ex10-18.htm	Edgar Link	pending
ex10-20.htm	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex3-1.htm	Edgar Link	pending
ex3-1_001.jpg	Edgar Link	pending
ex3-1_002.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nuze-20220930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nuze-20220930_def.xml	Edgar Link	unprocessable
nuze-20220930_cal.xml	Edgar Link	unprocessable
nuze-20220930_lab.xml	Edgar Link	unprocessable
nuze-20220930_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IMG
Stock $img

2022 Q4 Form 10-K Financial Statement

#000149315222036487 Filed on December 23, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IMG Stock $img

2022 Q4 Form 10-K Financial Statement

#000149315222036487 Filed on December 23, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IMG
Stock $img